Boston Scientific Corp.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $1.54B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $319.0M | 20.8% |
| Business Acquisitions | $560.0M | 36.5% |
| Other Investing | $131.0M | 8.5% |
| Net Cash Flow | $526.0M | 34.2% |